Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802
Debt
Debt-to-Equity Ratio1.29
Current Ratio2.24
Quick Ratio2.24
Price-To-Earnings
Trailing P/E Ratio-2.46
Forward P/E Ratio-8.41
P/E GrowthN/A
Sales & Book Value
Annual Sales$130.37 million
Price / Sales3.12
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees342
Outstanding Shares20,260,000
Market Cap$507.41 million
Cardlytics (NASDAQ:CDLX) Frequently Asked Questions
What is Cardlytics' stock symbol?
Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."
How were Cardlytics' earnings last quarter?
Cardlytics Inc (NASDAQ:CDLX) issued its earnings results on Tuesday, August, 14th. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.53) by $0.32. The business had revenue of $35.57 million for the quarter, compared to the consensus estimate of $34.89 million. Cardlytics's revenue for the quarter was up 8.4% on a year-over-year basis. View Cardlytics' Earnings History.
When is Cardlytics' next earnings date?
What price target have analysts set for CDLX?
6 analysts have issued twelve-month price targets for Cardlytics' shares. Their predictions range from $22.00 to $28.00. On average, they expect Cardlytics' stock price to reach $24.40 in the next year. This suggests a possible upside of 21.4% from the stock's current price. View Analyst Price Targets for Cardlytics.
What is the consensus analysts' recommendation for Cardlytics?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cardlytics.
What are Wall Street analysts saying about Cardlytics stock?
Here are some recent quotes from research analysts about Cardlytics stock:
- 1. According to Zacks Investment Research, "Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The purchase data includes debit, credit and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company also operates an advertising channel, Cardlytics Direct. Cardlytics Direct delivers tailored marketing for marketers and financial institutions. Cardlytics, Inc. is based in ATLANTA, United States. " (10/9/2018)
- 2. SunTrust Banks, Inc. analysts commented, "We hosted CDLX mgt for an NDR this week, during which mgt provided more color around the state of the business following 2Q earnings on 8/14, and progress on the all-important JPM Fargo relationships. As a digital ad channel designed to be bot and fraud proof with attractive ROI, CDLX is gaining enough scale with users and becoming a more relevant platform for advertisers, in our view. The focus now is on-boarding these two new partners while aggressively expanding the sales force to sell the growing ad inventory. We remain positive on CDLX and see ample opportunity for growth. Becoming The Industry Consolidator." (9/11/2018)
Who are some of Cardlytics' key competitors?
Some companies that are related to Cardlytics include TrueCar (TRUE), 21Vianet Group (VNET), HealthStream (HSTM), Internet Initiative Japan (IIJI), Jianpu Technology (JT), Aurora Mobile (JG), Model N (MODN), Internap (INAP), The Rubicon Project (RUBI), Edgewater Technology (EDGW), Synacor (SYNC), Sify Technologies (SIFY), Autoweb (AUTO), GigaMedia (GIGM) and Chinanet Online (CNET).
Who are Cardlytics' key executives?
Cardlytics' management team includes the folowing people:
- Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 55)
- Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 48)
- Mr. David Evans, CFO & Head of Corp. Devel.
- Mr. Sathish Gaddipati, Chief Technology Officer (Age 51)
- Mr. Kirk L. Somers, Chief Legal & Privacy Officer (Age 53)
When did Cardlytics IPO?
(CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.
How do I buy shares of Cardlytics?
Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cardlytics' stock price today?
One share of CDLX stock can currently be purchased for approximately $20.10.
How big of a company is Cardlytics?
Cardlytics has a market capitalization of $507.41 million and generates $130.37 million in revenue each year. The company earns $-19,640,000.00 in net income (profit) each year or ($8.02) on an earnings per share basis. Cardlytics employs 342 workers across the globe.
What is Cardlytics' official website?
How can I contact Cardlytics?
Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]
MarketBeat Community Rating for Cardlytics (NASDAQ CDLX)
MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
